ESSEX INVESTMENT MANAGEMENT CO LLC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 33 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2017$244,000
+117.9%
34,494
+116.1%
0.03%
+106.2%
Q2 2017$112,000
+47.4%
15,959
+45.8%
0.02%
+33.3%
Q1 2017$76,00010,9450.01%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2017
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders